Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2010 2
2011 3
2012 2
2013 2
2014 2
2015 2
2016 4
2017 8
2018 8
2019 11
2020 7
2021 10
2022 8
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK; CLEAR Trial Investigators. Motzer RJ, et al. J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. J Clin Oncol. 2024. PMID: 38227898 Free article. Clinical Trial.
Age-Dependent Changes in the Cochlea.
Fischer N, Johnson Chacko L, Glueckert R, Schrott-Fischer A. Fischer N, et al. Gerontology. 2020;66(1):33-39. doi: 10.1159/000499582. Epub 2019 May 22. Gerontology. 2020. PMID: 31117093 Review.
Persistence of IgG response to SARS-CoV-2.
Duysburgh E, Mortgat L, Barbezange C, Dierick K, Fischer N, Heyndrickx L, Hutse V, Thomas I, Van Gucht S, Vuylsteke B, Ariën KK, Desombere I. Duysburgh E, et al. Among authors: fischer n. Lancet Infect Dis. 2021 Feb;21(2):163-164. doi: 10.1016/S1473-3099(20)30943-9. Epub 2020 Dec 17. Lancet Infect Dis. 2021. PMID: 33341124 Free PMC article. No abstract available.
[Biologics for Chronic Rhinosinusitis].
Pinggera L, Innerhofer V, Fischer N, Riechelmann H. Pinggera L, et al. Among authors: fischer n. Laryngorhinootologie. 2020 Jul;99(7):483-493. doi: 10.1055/a-1026-2845. Epub 2020 Jun 25. Laryngorhinootologie. 2020. PMID: 32585720 German.
Influenza versus other respiratory viruses - assessing severity among hospitalised children, Belgium, 2011 to 2020.
Fischer N, Moreels S, Dauby N, Reynders M, Petit E, Gérard M, Lacor P, Daelemans S, Lissoir B, Holemans X, Magerman K, Jouck D, Bourgeois M, Delaere B, Quoilin S, Van Gucht S, Thomas I, Bossuyt N, Barbezange C. Fischer N, et al. Euro Surveill. 2023 Jul;28(29):2300056. doi: 10.2807/1560-7917.ES.2023.28.29.2300056. Euro Surveill. 2023. PMID: 37470740 Free PMC article.
Decision-Making among Experts in Advanced Hodgkin Lymphoma.
Hitz F, Lang N, Mey U, Mingrone W, Moccia A, Taverna C, Novak U, Stenner F, Schmidt A, Mamot C, Fischer N, Putora PM. Hitz F, et al. Among authors: fischer n. Oncology. 2023;101(3):159-165. doi: 10.1159/000526360. Epub 2022 Sep 27. Oncology. 2023. PMID: 36103806 Free article.
64 results